Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,082 | 74,536 | 84,878 | 107,016 | 63,297 |
| Receivables | 93,133 | 84,107 | 89,230 | 101,219 | 115,889 |
| Inventories | 75,650 | 80,135 | 83,589 | 74,808 | 71,368 |
| TOTAL | $271,702 | $266,518 | $278,756 | $302,714 | $269,749 |
| Non-Current Assets | |||||
| PPE Net | 24,516 | 24,245 | 26,673 | 26,267 | 24,702 |
| Intangibles | 244,040 | 241,746 | 249,901 | 253,374 | 261,166 |
| Other Non-Current Assets | 60,136 | 64,381 | 65,476 | 65,115 | 66,910 |
| TOTAL | $328,692 | $330,372 | $342,050 | $344,756 | $352,778 |
| Total Assets | $600,394 | $596,890 | $620,806 | $647,470 | $622,527 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50,000 | 40,000 | 35,000 | 35,000 | 35,000 |
| Accounts payable and accrued liabilities | 23,429 | 27,597 | 31,654 | 33,284 | 27,253 |
| Accrued Expenses | 44,236 | 39,034 | 38,857 | 45,255 | 54,451 |
| TOTAL | $145,752 | $132,008 | $132,230 | $142,089 | $142,821 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,840 | 25,697 | 51,761 | 64,713 | 19,665 |
| Deferred Revenues | 21,308 | 20,034 | 21,186 | 22,823 | 20,246 |
| Other Non-Current Liabilities | 27,410 | 28,932 | 27,075 | 28,480 | 29,667 |
| TOTAL | $43,548 | $69,415 | $93,103 | $107,228 | $63,583 |
| Total Liabilities | $189,300 | $201,423 | $225,333 | $249,317 | $206,404 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,874 | 33,868 | 33,871 | 33,802 | 34,105 |
| Common Shares | 342,828 | 339,665 | 337,338 | 334,296 | 344,476 |
| Retained earnings | 71,309 | 66,106 | 75,422 | 84,325 | 87,922 |
| Other shareholders' equity | -3,043 | -10,304 | -17,287 | -20,468 | -16,275 |
| TOTAL | $411,094 | $395,467 | $395,473 | $398,153 | $416,123 |
| Total Liabilities And Equity | $600,394 | $596,890 | $620,806 | $647,470 | $622,527 |